Dilute Betadine Lavage Before Closure for the Prevention of Acute Postoperative Deep Periprosthetic Joint Infection

Journal of Arthroplasty

Volumn 27, Issue 1, 2012, Pages 27-30

  Brown, Nicholas M ^a   Cipriano, Cara A ^b   Moric, Mario ^c   Sporer, Scott M ^b   Della Valle, Craig J ^b  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY   (United States)

Author keywords

Betadine lavage; Periprosthetic joint infection; THA; TKA

Indexed keywords

POVIDONE IODINE;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; INFECTIOUS ARTHRITIS; LAVAGE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PROSTHESIS INFECTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; WOUND CLOSURE;

ACUTE DISEASE; ANTI-INFECTIVE AGENTS, LOCAL; FEMALE; HUMANS; MALE; MIDDLE AGED; POVIDONE-IODINE; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; THERAPEUTIC IRRIGATION; WOUND CLOSURE TECHNIQUES;

EID: 83555174594     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2011.03.034     Document Type: Article

References (43)

1. Jamsen E., Huhtala H., Puolakka T., et al. Risk factors for infection after knee arthroplasty. A register-based analysis of 43,149 cases. J Bone Joint Surg Am 2009, 91:38.
2. Peersman G., Laskin R., Davis J., et al. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res 2001, 15.
3. Pulido L., Ghanem E., Joshi A., et al. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 2008, 466:1710.
4. Choong P.F., Dowsey M.M., Carr D., et al. Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampinbased regimen. Acta Orthop 2007, 78:755.
5. Phillips J.E., Crane T.P., Noy M., et al. The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J Bone Joint Surg Br 2006, 88:943.
6. Kurtz S., Ong K., Lau E., et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007, 89:780.
7. Chundamala J., Wright J.G. The efficacy and risks of using povidone-iodine irrigation to prevent surgical site infection: an evidence-based review. Can J Surg 2007, 50:473.
8. Cheng M.T., Chang M.C., Wang S.T., et al. Efficacy of dilute Betadine solution irrigation in the prevention of postoperative infection of spinal surgery. Spine (Phila Pa 1976) 2005, 30:1689.
9. Oduwole K.O., Glynn A.A., Molony D.C., et al. Anti-biofilm activity of sub-inhibitory povidone-iodine concentrations against Staphylococcus epidermidis and Staphylococcus aureus. J Orthop Res 2010, 28:1252.
10. Goldenheim P.D. In vitro efficacy of povidone-iodine solution and cream against methicillin-resistant Staphylococcus aureus. Postgrad Med J 1993, 69(Suppl 3):S62.
11. Haley C.E., Marling-Cason M., Smith J.W., et al. Bactericidal activity of antiseptics against methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1985, 21:991.
12. Hill R.L., Casewell M.W. The in-vitro activity of povidone-iodinecream against Staphylococcus aureus and its bioavailability in nasal secretions. J Hosp Infect 2000, 45:198.
13. McLure A.R., Gordon J. In-vitro evaluation of povidone-iodine and chlorhexidine against methicillin-resistant Staphylococcus aureus. J Hosp Infect 1992, 21:291.
14. Reimer K., Wichelhaus T.A., Schafer V., et al. Antimicrobial effectiveness of povidone-iodine and consequences for new application areas. Dermatology 2002, 204(Suppl 1):114.
15. Block C., Robenshtok E., Simhon A., et al. Evaluation of chlorhexidine and povidone iodine activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis using a surface test. J Hosp Infect 2000, 46:147.
16. Yasuda T., Yoshimura S., Katsuno Y., et al. Comparison of bactericidal activities of various disinfectants against methicillin-sensitive Staphylococcus aureus and methicillin-resistant Staphylococcus aureus. Postgrad Med J 1993, 69(Suppl 3):S66.
17. Kaysinger K.K., Nicholson N.C., Ramp W.K., et al. Toxic effects of wound irrigation solutions on cultured tibiae and osteoblasts. J Orthop Trauma 1995, 9:303.
18. Lonner J.H., Desai P., Dicesare P.E., et al. The reliability of analysis of intraoperative frozen sections for identifying active infection during revision hip or knee arthroplasty. J Bone Joint Surg Am 1996, 78:1553.
19. Hope P.G., Kristinsson K.G., Norman P., et al. Deep infection of cemented total hip arthroplasties caused by coagulase-negative staphylococci. J Bone Joint Surg Br 1989, 71:851.
20. Taylor G.J., Leeming J.P., Bannister G.C. Effect of antiseptics, ultraviolet light and lavage on airborne bacteria in a model wound. J Bone Joint Surg Br 1993, 75:724.
21. Espehaug B., Engesaeter L.B., Vollset S.E., et al. Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995. J Bone Joint Surg Br 1997, 79:590.
22. Lidgren L. Joint prosthetic infections: a success story. Acta Orthop Scand 2001, 72:553.
23. Nelson J.P., Glassburn A.R., Talbott R.D., et al. The effect of previous surgery, operating room environment, and preventive antibiotics on postoperative infection following total hip arthroplasty. Clin Orthop Relat Res 1980, 167.
24. Ong K.L., Kurtz S.M., Lau E., et al. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty 2009, 24:105.
25. Mahomed N.N., Barrett J.A., Katz J.N., et al. Rates and outcomes of primary and revision total hip replacement in the United States medicare population. J Bone Joint Surg Am 2003, 85-A:27.
26. Urquhart D.M., Hanna F.S., Brennan S.L., et al. Incidence and risk factors for deep surgical site infection after primary total hip arthroplasty: a systematic review. J Arthroplasty 2009.
27. Taylor G.J., Bannister G.C., Leeming J.P. Wound disinfection with ultraviolet radiation. J Hosp Infect 1995, 30:85.
28. Berg-Perier M., Cederblad A., Persson U. Ultraviolet radiation and ultra-clean air enclosures in operating rooms. UV-protection, economy, and comfort. J Arthroplasty 1992, 7:457.
29. Berg M., Bergman B.R., Hoborn J. Ultraviolet radiation compared to an ultra-clean air enclosure. Comparison of air bacteria counts in operating rooms. J Bone Joint Surg Br 1991, 73:811.
30. Ritter M.A., Olberding E.M., Malinzak R.A. Ultraviolet lighting during orthopaedic surgery and the rate of infection. J Bone Joint Surg Am 2007, 89:1935.
31. Lowell J.D., Kundsin R.B. The operating room and the ultraviolet environment. Med Instrum 1978, 12:161.
32. Goldner J.L., Allen B.L. Ultraviolet light in orthopedic operating rooms at Duke University. Thirty-five years' experience, 1937-1973. Clin Orthop Relat Res 1973, 195.
33. Salvati E.A., Robinson R.P., Zeno S.M., et al. Infection rates after 3175 total hip and total knee replacements performed with and without a horizontal unidirectional filtered air-flow system. J Bone Joint Surg Am 1982, 64:525.
34. Lidwell O.M., Lowbury E.J., Whyte W., et al. Effect of ultraclean air in operating rooms on deep sepsis in the joint after total hip or knee replacement: a randomised study. Br Med J (Clin Res Ed) 1982, 285:10.
35. Ahl T., Dalen N., Jorbeck H., et al. Air contamination during hip and knee arthroplasties. Horizontal laminar flow randomized vs. conventional ventilation. Acta Orthop Scand 1995, 66:17.
36. Brandt C., Hott U., Sohr D., et al. Operating room ventilation with laminar airflow shows no protective effect on the surgical site infection rate in orthopedic and abdominal surgery. Ann Surg 2008, 248:695.
37. Taylor G.J., Bannister G.C. Infection and interposition between ultraclean air source and wound. J Bone Joint Surg Br 1993, 75:503.
38. Berg M., Bergman B.R., Hoborn J. Shortwave ultraviolet radiation in operating rooms. J Bone Joint Surg Br 1989, 71:483.
39. Carlsson A.S., Nilsson B., Walder M.H., et al. Ultraviolet radiation and air contamination during total hip replacement. J Hosp Infect 1986, 7:176.
40. Parvizi J., Saleh K.J., Ragland P.S., et al. Efficacy of antibiotic-impregnated cement in total hip replacement. Acta Orthop 2008, 79:335.
41. Namba R.S., Chen Y., Paxton E.W., et al. Outcomes of routine use of antibiotic-loaded cement in primary total knee arthroplasty. J Arthroplasty 2009, 24:44.
42. Hanssen A.D. Prophylactic use of antibiotic bone cement: an emerging standard-in opposition. J Arthroplasty 2004, 19:73.
43. Jiranek W.A., Hanssen A.D., Greenwald A.S. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J Bone Joint Surg Am 2006, 88:2487.